Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

What is Population Genetics?01:25

What is Population Genetics?

65.0K
A population is composed of members of the same species that simultaneously live and interact in the same area. When individuals in a population breed, they pass down their genes to their offspring. Many of these genes are polymorphic, meaning that they occur in multiple variants. Such variations of a gene are referred to as alleles. The collective set of all the alleles within a population is known as the gene pool.
65.0K
What are Populations and Communities?00:30

What are Populations and Communities?

38.0K
Overview
38.0K
Conservation of Small Populations02:04

Conservation of Small Populations

17.5K
Small population sizes put a species at extreme risk of extinction due to a lack of variation, and a consequent decrease in adaptability. This weakens the chances of survival under pressures such as climate change, competition from other species, or new diseases. Large populations are more likely to survive pressures such as these, as such populations are more likely to harbor individuals that have genetic variants that are adaptive under new stresses. Small populations are much less...
17.5K
Population Growth00:57

Population Growth

28.8K
Population size is dynamic, increasing with birth rates and immigration, and decreasing with death rates and emigration. In ideal conditions with unlimited resources, populations can increase exponentially, which plots as a J-shaped growth rate curve of population size against time. This type of curve is characteristic of newly-introduced invasive species, or populations that have suffered catastrophic declines and are rebounding.
28.8K
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

490
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
490
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

3.2K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
3.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neural regulation of tumor progression: implications for hepatocellular carcinoma.

Frontiers in immunology·2026
Same author

Targeted therapy in advanced <i>BRAF</i>-mutated colorectal cancer: systematic review and network meta-analysis.

BMJ (Clinical research ed.)·2025
Same author

Anlotinib plus sintilimab as first-line treatment for patients with advanced colorectal cancer (APICAL-CRC): an open-label, single-arm, phase II trial.

Signal transduction and targeted therapy·2025
Same author

Impact of molecular tumor board on clinical outcomes in patients with refractory solid tumors: a real-world study.

The oncologist·2025
Same author

Anlotinib plus toripalimab as a first-line treatment in patients with advanced gastric cancer and performance status 2: the phase II APICAL-GC trial.

Nature communications·2025
Same author

Case report: Aumolertinib plus gumarontinib in a patient with EGFR mutated non-small-cell lung cancer harboring acquired MET amplification following progression on afatinib plus crizotinib.

Frontiers in pharmacology·2025

Related Experiment Video

Updated: Feb 14, 2026

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
06:59

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis

Published on: August 26, 2025

619

Primary pulmonary leiomyosarcoma: A population-based study.

Bao-Dong Qin1, Xiao-Dong Jiao1, Yuan-Sheng Zang1

  • 1Department of Medical Oncology, Changzheng Hospital, Naval Medical University, Shanghai, China.

Lung Cancer (Amsterdam, Netherlands)
|February 8, 2018
PubMed
Summary
This summary is machine-generated.

Primary pulmonary leiomyosarcoma (PPL) survival is linked to distant stage and surgical intervention. Cancer-directed surgery significantly improves overall survival for PPL patients.

Keywords:
OutcomesPrimary pulmonary leiomyosarcomaSEER database

More Related Videos

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
07:10

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Published on: August 24, 2019

10.5K
Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.3K

Related Experiment Videos

Last Updated: Feb 14, 2026

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
06:59

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis

Published on: August 26, 2025

619
Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
07:10

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Published on: August 24, 2019

10.5K
Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.3K

Area of Science:

  • Oncology
  • Pulmonary Medicine
  • Surgical Pathology

Background:

  • Primary pulmonary leiomyosarcoma (PPL) is a rare lung cancer with limited understanding of its clinical behavior.
  • Existing knowledge on PPL is primarily based on isolated case reports, necessitating further investigation into survival-associated factors.

Purpose of the Study:

  • To identify clinicopathological features and prognostic factors associated with patient survival in primary pulmonary leiomyosarcoma.
  • To analyze the impact of treatment modalities, specifically surgery and radiotherapy, on overall survival for PPL patients.

Main Methods:

  • A population-based cohort study utilizing prospectively collected data from the Surveillance, Epidemiology, and End Results (SEER) database (1973-2013).
  • Inclusion criteria comprised patients with a histological diagnosis of PPL.
  • Data analyzed included demographics, treatment details, and patient outcomes, with survival analysis performed using multivariate Cox regression.

Main Results:

  • The study included 231 PPL patients (mean age 65.8 years).
  • Distant stage was identified as an independent negative prognostic factor (HR=2.22), while cancer-directed surgery emerged as an independent protective factor, reducing mortality risk by 57% (HR=0.43).
  • Cancer-directed surgery significantly improved median overall survival (OS) by 29 months (33.0 vs. 4.0 months; p < .01), with 5-year OS at 22.2%.

Conclusions:

  • Primary pulmonary leiomyosarcoma is a rare malignancy where distant stage and surgical resection are significant prognostic indicators.
  • While surgical intervention improves survival, further research with larger cohorts and comprehensive data is required for a deeper understanding of PPL.